CUVITRU is a ready-to-use liquid medicine that is given under the skin (subcutaneously) to treat primary immunodeficiency (PI) in people 2 years and older.
CUVITRU is a ready-to-use liquid medicine that is given under the skin (subcutaneously) to treat primary immunodeficiency (PI) in people 2 years and older.
CUVITRU [Immune Globulin Subcutaneous (Human)] 20%
over the course of 1 year
infections of any kind
Those taking CUVITRU had infections of any kind at a rate of 2.41 per patient-year.
in the hospital
The rate of days spent in a hospital due to infection was 0.06 for those taking CUVITRU per patient-year.†1
of missed work or school
Those taking CUVITRU had about 1 day in which they weren’t able to perform normal daily activities due to illness or infection.1,2
*CUVITRU was studied in 77 people with primary immunodeficiency (PI) ≥2 years of age, with the main goal of measuring how many acute serious bacterial infections (ASBIs) were experienced over the course of 1 year. ASBIs are short-term but serious infections that require immediate medical care. For an immunoglobulin (Ig) treatment to be effective, the rate of ASBIs must be <1 per year. On average, people taking CUVITRU experienced 0.012 per year, which is significantly less.
†One ASBI that occurred during the study was a case of pneumonia in a 78-year-old person.
of infusions were completed without a reduction, interruption or
discontinuation due to tolerability
In the North American clinical study1,2
There was a low rate of local side effects with CUVITRU, regardless of how fast or how much was infused.1
(4247/4327) of infusions in the clinical study* had no side effects
where the medicine is given,§ such as pain, itching, and redness1
of infusions resulted in a local
side effect. They were mild or moderate1
‡CUVITRU was studied in 77 people with primary immunodeficiency (PI) ≥2 years of age, with the main goal of measuring how many acute serious bacterial infections (ASBIs) were experienced over the course of 1 year. ASBIs are short-term but serious infections that require immediate medical care.
§Infusion site side effects generally go away within a few hours and are less likely after the first few infusions.
Your doctor is your best resource for questions about side effects.
Get thought startersSee how CUVITRU’s administration options helped 3 people with PI fit the treatment into their lives.
Read patient stories